Gonorrhea in China shows waning susceptibility to WHO-recommended antibiotics
(PLOS) Neisseria gonorrhoeae strains resistant to azithromycin and/or with decreased susceptibility to ceftriaxone are common in China, according to a prevalence study published this week in PLOS Medicine. The study also showed that the prevalence of dual resistance in N. gonorrhoeae isolates increased from 2013 to 2016. The results suggest that dual therapy with azithromycin and ceftriaxone, recommended by WHO and many countries to treat gonorrhea, may not prove effective in China.
Though the comparison is a bit apples and oranges between now and 1918, the staggering death toll is tragic in any era.Medscape Medical News
A new report claims better federal government coordination is needed, along with an improved public health infrastructure, more tests, and better data on critical supplies.Medscape Medical News
Pediatric Dermatology Part I
Esther E. Freeman and Devon E. McMahon
BRUCE H. THIERS, MD